ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Bayer plans filings for prostate cancer drug darolutamide
pharmaphorum
December 20, 2018Bayer is planning regulatory filings of darolutamide in prostate cancer following phase III trial results showing it helped prevent the disease from spreading, in a niche where Pfizer and Johnson & Johnson have already gained a foothold.
Pharma Sources Insight July 2025
